XML 48 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock incentive plans (Tables)
12 Months Ended
Dec. 31, 2023
Stock incentive plans [Abstract]  
Assumptions Used in Option Valuation Calculations
The table below indicates the key assumptions (on a weighted-average basis) used in the option valuation calculations for options granted in 2023 and 2022 and a discussion of our methodology for developing each of the assumptions used in the valuation model:

   
Years ended December 31,
 
 
2023
   
2022
 
Expected option term (in years)
   
7.0
     
7.1
 
Expected volatility
   
55.6
%
   
51.3
%
Risk-free interest rate
   
4.2
%
   
2.2
%
Dividend yield
   
0.0
%
   
0.0
%
Stock Option Activity
Equity award activity in the 2005 Equity Incentive Plan and the 2014 Equity Incentive Plan, as amended, is summarized below:

 
Stock Options
   
Restricted Stock Units
 
   
Number of Shares
   
Average Price*
   
Number of Units
   
Average Price**
 
Outstanding at December 31, 2022
   
1,355,955
   
$
9.08
     
214,286
   
$
9.28
 
Granted
   
309,800
     
6.91
     
210,100
     
7.21
 
Exercised
   
(1,875
)
   
4.25
     
(58,705
)
   
9.55
 
Forfeited
   
(271,655
)
   
7.72
     
(181,145
)
   
8.34
 
Expired
   
(77,750
)
   
8.90
     
     
 
Outstanding at December 31, 2023
   
1,314,475
   
$
8.82
     
184,536
   
$
7.76
 

*
weighted average exercise price per share
**
weighted average grant stock price per share
Equity Awards Vested and Expected to Vest
The following summarizes information about equity awards outstanding that are vested and expect to vest and equity awards that are exercisable at December 31, 2023:

 
Equity Awards Vested and Expected to Vest
   
Equity Awards That Are Exercisable
 
   
Awards
   
Average Price*
   
Aggregate Intrinsic Value
   
Remaining Term**
   
Awards
   
Average Price*
   
Aggregate Intrinsic Value
   
Remaining Term**
 
Stock Options
   
1,314,475
   
$
8.82
   
$
316
     
4.0
     
968,972
   
$
9.31
   
$
167
     
2.2
 
Restricted stock units
   
184,536
     
     
1,288
     
2.7
     
     
     
     
 

*
weighted average exercise price per share
**
weighted-average contractual remaining term in years